Feng Chi Biotech Corp. (6744) Stock Statistics & Valuation Metrics
Total Valuation
Feng Chi Biotech Corp. has a market cap or net worth of TWD 179.95M. The enterprise value is ―.
- Market Cap
- TWD 179.95M
- Enterprise Value
- ―
Share Statistics
Feng Chi Biotech Corp. has 14,690,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 14,690,000
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Feng Chi Biotech Corp.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.82%.
- Return on Equity (ROE)
- 0.06
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 4.82%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 5.54M
- Profits Per Employee
- 452.31K
- Employee Count
- 32
- Asset Turnover
- 0.62
- Inventory Turnover
- 2.83
Valuation Ratios
The current PE Ratio of Feng Chi Biotech Corp. is 19.38. Feng Chi Biotech Corp.’s PEG ratio is -0.54.
- PE Ratio
- 19.38
- PS Ratio
- 1.18
- PB Ratio
- 0.84
- Price to FCF
- 114.47
- Price to Operating Cash Flow
- 79.40
- PEG Ratio
- -0.54
Income Statement
In the last 12 months, Feng Chi Biotech Corp. had revenue of 177.36M and earned 14.47M in profits. Earnings per share was 0.94.
- Revenue
- 177.36M
- Gross Profit
- 79.16M
- Operating Income
- 13.85M
- Pretax Income
- 16.93M
- Net Income
- 14.47M
- EBITDA
- 25.97M
- Earnings Per Share (EPS)
- 0.94
Cash Flow
In the last 12 months, operating cash flow was 2.42M and capital expenditures -803,000, giving a free cash flow of 1.62M billion.
- Operating Cash Flow
- 2.42M
- Free Cash Flow
- 1.62M
- Free Cash Flow per Share
- 0.11
Dividends & Yields
Feng Chi Biotech Corp. pays an annual dividend of ―, resulting in a dividend yield of 6.86%
- Dividend Per Share
- ―
- Dividend Yield
- 6.86%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.87%
- Earnings Yield
- 5.15%
Stock Price Statistics
- Beta
- -0.00
- 52-Week Price Change
- -37.02%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 30.09
- Average Volume (3m)
- 34.05K
Financial Position
Feng Chi Biotech Corp. as a current ratio of 5.14, with Debt / Equity ratio of 2.26%
- Current Ratio
- 5.14
- Quick Ratio
- 4.38
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.46
- Interest Coverage Ratio
- 76.50
Taxes
In the past 12 months, Feng Chi Biotech Corp. has paid 2.46M in taxes.
- Income Tax
- 2.46M
- Effective Tax Rate
- 0.15
Enterprise Valuation
Feng Chi Biotech Corp. EV to EBITDA ratio is 9.05, with an EV/FCF ratio of 110.31.
- EV to Sales
- 1.14
- EV to EBITDA
- 9.05
- EV to Free Cash Flow
- 110.31
- EV to Operating Cash Flow
- 73.71
Balance Sheet
Feng Chi Biotech Corp. has TWD 171.85M in cash and marketable securities with TWD 4.04M in debt, giving a net cash position of TWD 167.81M billion.
- Cash & Marketable Securities
- TWD 171.85M
- Total Debt
- TWD 4.04M
- Net Cash
- TWD 167.81M
- Net Cash Per Share
- TWD 11.42
- Tangible Book Value Per Share
- TWD 15.04
Margins
Gross margin is 44.87%, with operating margin of 4.55%, and net profit margin of 6.31%.
- Gross Margin
- 44.87%
- Operating Margin
- 4.55%
- Pretax Margin
- 7.20%
- Net Profit Margin
- 6.31%
- EBITDA Margin
- 12.55%
- EBIT Margin
- 4.55%
Analyst Forecast
The average price target for Feng Chi Biotech Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -12.75%
- EPS Growth Forecast
- -36.66%
